2013
DOI: 10.1016/j.jss.2013.03.028
|View full text |Cite
|
Sign up to set email alerts
|

Dexmedetomidine ameliorates TNBS-induced colitis by inducing immunomodulator effect

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 39 publications
0
15
0
Order By: Relevance
“…These findings were later corroborated by another clinical study (Furlan et al, 2006), and more recently also by animal experiments (Erdogan Kayhan et al, 2013). In contrast, there is evidence that activation of a 2 -ARs localized on macrophages and neutrophils induces the release of proinflammatory cytokines (Spengler et al, 1994;Flierl et al, 2007) and enhances acute inflammatory lung injury in rats and mice (Flierl et al, 2007).…”
Section: Discussionmentioning
confidence: 53%
See 2 more Smart Citations
“…These findings were later corroborated by another clinical study (Furlan et al, 2006), and more recently also by animal experiments (Erdogan Kayhan et al, 2013). In contrast, there is evidence that activation of a 2 -ARs localized on macrophages and neutrophils induces the release of proinflammatory cytokines (Spengler et al, 1994;Flierl et al, 2007) and enhances acute inflammatory lung injury in rats and mice (Flierl et al, 2007).…”
Section: Discussionmentioning
confidence: 53%
“…These models differ in several aspects, such as pathomechanism, clinical/-histologic picture, and cytokine profile (Strober et al, 2002;Alex et al, 2009); therefore, it is possible that a drug is able to influence the development of inflammation in one, but not in another model (Park et al, 2004). Nevertheless, it has to be emphasized that, regarding the role of a 2 -ARs, controversial results were reported by using the same colitis model (TNBS) as well (Bai et al, 2009;Erdogan Kayhan et al, 2013). Thus, other factors, such as using different a 2 -AR ligands with potential additional receptorial actions (dexmedetomidine, UK14304), different amounts of the chemical inducer (2.5 and 3.75 mg TNBS), or different ages of experimental animals (5-6 and 7-8 weeks), may also contribute to the diverging findings.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sedatives influence a number of physiological systems and responses, including the immune system, leading to the concept of sedative-induced immunomodulation (Galley et al, 2000; Taniguchi et al, 2004; Maclaren, 2009; Qiao et al, 2009; Sanders et al, 2009; Kayhan et al, 2013). Because of the potential for infections and sepsis in intensive care settings, it has been suggested that immunomodulatory properties should be considered in the clinical decision-making process regarding the inclusion of sedatives in drug regimens (Sanders et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…These findings corroborate the results of studies previously reported by other authors. 10,11 In our investigation, the efficacy and safety of incision local ropivacaine analgesia for patients undergoing hepa- tectomy was evaluated by comparing the postoperative analgesic effect and adverse reactions following open hepatectomy. Ropivacaine is a long-acting local amide anesthetic with low neurotoxicity and cardiotoxicity.…”
Section: Discussionmentioning
confidence: 99%